Publication in Current Oncology
Prostate cancer remains one of the most common cancers among men. As treatment options expand, so do the...
Lorem ipsum dolor sit amet, consecte adipiscing elit, sed do eiusmod tempor incidiunt ut labore
Lorem ipsum dolor sit amet, consecte adipiscing elit, sed do eiusmod tempor incidiunt ut labore
Lorem ipsum dolor sit amet, consecte adipiscing elit, sed do eiusmod tempor incidiunt ut labore
Lorem ipsum dolor sit amet, consecte adipiscing elit, sed do eiusmod tempor incidiunt ut labore
Lorem ipsum dolor sit amet, consecte adipiscing elit, sed do eiusmod tempor incidiunt ut labore
Lorem ipsum dolor sit amet, consecte adipiscing elit, sed do eiusmod tempor incidiunt ut labore
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
Vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint eiusmod tempor incididunt ut labore et dolore magna aliqua
Vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint eiusmod tempor incididunt ut labore et dolore magna aliqua
Vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint eiusmod tempor incididunt ut labore et dolore magna aliqua
Prostate cancer remains one of the most common cancers among men. As treatment options expand, so do the...
Up to 1,600 patients are expected to be enrolled in this study across Europe. The clinical trial will...
Watch this highly informative interview in which Dr Guillaume Grisay introduces the DE-ESCALATE trial in a conversation with...
© The DE-ESCALATE Consortium 2023-2028. This project has received funding from the European Union’s HORIZON-MISS-CANCER-2022-01 under grant agreement Nº (101104574 ). Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.
Copyright © 2025 All rights reserved.
